Literature DB >> 17403120

Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus.

P C Y Tong1, A P Kong, W Y So, X Yang, M C Y Ng, C S Ho, R C W Ma, R Ozaki, V Ng, C C Chow, C W K Lam, J C N Chan, C S Cockram.   

Abstract

AIMS: To examine the effect of albuminuria and retinopathy on the risk of cardiovascular and renal events, and all-cause mortality in patients with Type 2 diabetes.
METHODS: A post-hoc analysis of 4416 Chinese patients without macrovascular complications at baseline (age 57.6 +/- 13.3 years). Glomerular filtration rate (eGFR) was estimated by the abbreviated Modification of Diet in Renal Disease Study Group Formula, further adjusted for Chinese ethnicity. Clinical end points were all-cause mortality, cardiovascular events (heart failure or angina, myocardial infarction, lower limb amputation, re-vascularization procedures and stroke) and renal end points (reduction in eGFR by more than 50% or eGFR < 15 ml/min/1.73 m2 or death as a result of renal causes or need for dialysis).
RESULTS: Compared with individuals without complications, subjects with retinopathy and macroalbuminuria had higher rates of cardiovascular events (14.1 vs. 2.4%), renal events (40.0 vs. 0.8%) and death (9.3 vs. 1.7%, P < 0.001). For composite event of death, cardiovascular and renal events, the presence of retinopathy, microalbuminuria alone, macroalbuminuria alone, retinopathy with microalbuminuria or retinopathy with macroalbuminuria increased the risk [hazard ratio (95% CI)] by 1.61 (1.05 to 2.47; P = 0.04), 1.93 (1.38 to 2.69; P < 0.001), 4.34 (3.02 to 6.22; P < 0.001), 2.59 [1.76 to 3.81; P < 0.001) and 6.83 (4.89 to 9.55; P < 0.001) fold, respectively. The relative excess risk as a result of interaction between retinopathy and macroalbuminuria was 15.31, implying biological interaction in the development of renal events.
CONCLUSIONS: In Chinese patients with Type 2 diabetes, retinopathy interacts with macroalbuminuria to increase the risk of composite cardio-renal events.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17403120     DOI: 10.1111/j.1464-5491.2007.02145.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  19 in total

1.  Proliferative retinopathy and proteinuria predict mortality rate in type 1 diabetic patients from Fyn County, Denmark.

Authors:  J Grauslund; A Green; A K Sjølie
Journal:  Diabetologia       Date:  2008-02-23       Impact factor: 10.122

2.  Mortality in Older Persons with Retinopathy and Concomitant Health Conditions: The Age, Gene/Environment Susceptibility-Reykjavik Study.

Authors:  Diana E Fisher; Fridbert Jonasson; Ronald Klein; Palmi V Jonsson; Gudny Eiriksdottir; Lenore J Launer; Vilmundur Gudnason; Mary Frances Cotch
Journal:  Ophthalmology       Date:  2016-04-07       Impact factor: 12.079

Review 3.  Angiotensin blockade to reduce microvascular damage in diabetes mellitus.

Authors:  Roland E Schmieder; Stephan Martin; Gabriele E Lang; Peter Bramlage; Michael Böhm
Journal:  Dtsch Arztebl Int       Date:  2009-08-24       Impact factor: 5.594

4.  Diabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in Japanese type 2 diabetic patients: Japan Diabetes Complications Study.

Authors:  Tatsumi Moriya; Shiro Tanaka; Ryo Kawasaki; Yasuo Ohashi; Yasuo Akanuma; Nobuhiro Yamada; Hirohito Sone; Hidetoshi Yamashita; Shigehiro Katayama
Journal:  Diabetes Care       Date:  2013-04-25       Impact factor: 19.112

5.  The Complexity of Vascular and Non-Vascular Complications of Diabetes: The Hong Kong Diabetes Registry.

Authors:  Juliana C N Chan; Wingyee So; Ronald C W Ma; Peter C Y Tong; Rebecca Wong; Xilin Yang
Journal:  Curr Cardiovasc Risk Rep       Date:  2011-04-12

Review 6.  Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies.

Authors:  Caroline K Kramer; Ticiana C Rodrigues; Luis H Canani; Jorge L Gross; Mirela J Azevedo
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

7.  Microvascular disease and cardiovascular outcomes among individuals with type 2 diabetes.

Authors:  Arnaud D Kaze; Prasanna Santhanam; Sebhat Erqou; Alain G Bertoni; Rexford S Ahima; Justin B Echouffo-Tcheugui
Journal:  Diabetes Res Clin Pract       Date:  2021-05-12       Impact factor: 8.180

8.  Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry.

Authors:  Andrea O Y Luk; Wing-Yee So; Ronald C W Ma; Alice P S Kong; Risa Ozaki; Vanessa S W Ng; Linda W L Yu; Winnie W Y Lau; Xilin Yang; Francis C C Chow; Juliana C N Chan; Peter C Y Tong
Journal:  Diabetes Care       Date:  2008-10-03       Impact factor: 17.152

9.  The impacts of albuminuria and low eGFR on the risk of cardiovascular death, all-cause mortality, and renal events in diabetic patients: meta-analysis.

Authors:  Tadashi Toyama; Kengo Furuichi; Toshiharu Ninomiya; Miho Shimizu; Akinori Hara; Yasunori Iwata; Shuichi Kaneko; Takashi Wada
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

10.  Four-year incidence of diabetic retinopathy in a Spanish cohort: the MADIABETES study.

Authors:  Miguel Á Salinero-Fort; Francisco Javier San Andrés-Rebollo; Carmen de Burgos-Lunar; Francisco Jesús Arrieta-Blanco; Paloma Gómez-Campelo
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.